{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:27:15Z","timestamp":1720484835907},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ejim.2015.12.014","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T15:46:30Z","timestamp":1452181590000},"page":"98-103","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Renin\u2013angiotensin\u2013aldosterone system inhibitors lower hemoglobin and hematocrit only in renal transplant recipients with initially higher levels"],"prefix":"10.1016","volume":"29","author":[{"given":"I.","family":"Mikolasevic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Zaputovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Zibar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Begic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zutelija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Klanac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Majurec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Simundic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Minazek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Orlic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 5","key":"10.1016\/j.ejim.2015.12.014_bb0005","doi-asserted-by":"crossref","first-page":"V54","DOI":"10.1093\/ndt\/gfh1057","article-title":"Anemia after renal transplantation","volume":"19","author":"Vanrenterghem","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2015.12.014_bb0010","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.transproceed.2004.09.014","article-title":"Valsartan-induced hematocrit changes in renal transplant patients","volume":"37","author":"Flores","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ejim.2015.12.014_bb0015","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/ndt\/gfk058","article-title":"A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period","volume":"21","author":"Formica","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2015.12.014_bb0020","first-page":"809","article-title":"Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the early period after kidney transplantation","volume":"37","author":"Orli\u0107","year":"2013","journal-title":"Coll Antropol"},{"key":"10.1016\/j.ejim.2015.12.014_bb0025","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.transproceed.2005.01.043","article-title":"Renoprotective effect of early inhibition of the renin\u2013angiotensin system in renal transplant recipients","volume":"37","author":"Montanaro","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ejim.2015.12.014_bb0030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1399-0012.2008.00807.x","article-title":"Determinants and patterns of renin\u2013angiotensin system inhibitors' prescription in the first year following kidney transplantation","volume":"22","author":"Thilly","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ejim.2015.12.014_bb0035","first-page":"57","article-title":"Ramipril in post-renal transplant erythrocytosis","volume":"20","author":"Esposito","year":"2007","journal-title":"J Nephrol"},{"key":"10.1016\/j.ejim.2015.12.014_bb0040","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/j.1600-6143.2007.01928.x","article-title":"Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence","volume":"7","author":"Hiremath","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ejim.2015.12.014_bb0045","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/BF00496034","article-title":"Captopril in severe childhood hypertension\u2014reversible anemia with high dosage","volume":"144","author":"Verhaaren","year":"1986","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ejim.2015.12.014_bb0050","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1172\/JCI119769","article-title":"Angiotensin II stimulates proliferation of normal early erythroid progenitors","volume":"100","author":"Mrug","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2015.12.014_bb0055","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1681\/ASN.V961104","article-title":"Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis","volume":"9","author":"Julian","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2015.12.014_bb0060","doi-asserted-by":"crossref","unstructured":"Ajmal A, Gessert CE, Johnson BP1, Renier CM, Palcher JA Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels BMC Res Notes 2013;6:443.","DOI":"10.1186\/1756-0500-6-443"},{"key":"10.1016\/j.ejim.2015.12.014_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129484","article-title":"Erythropoiesis and blood pressure are regulated via AT1 receptor by distinctive pathways","volume":"10","author":"Kato","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2015.12.014_bb0070","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0272-6386(12)81129-2","article-title":"Enalapril-associated anemia in renal transplant recipients treated for hypertension","volume":"17","author":"Vlahakos","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2015.12.014_bb0075","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/00007890-200203150-00022","article-title":"Angiotensin converting enzyme inhibition in chronic allograft nephropathy","volume":"73","author":"Lin","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2015.12.014_bb0080","doi-asserted-by":"crossref","first-page":"145828","DOI":"10.1155\/2015\/145828","article-title":"Interplay of vitamin D, erythropoiesis, and the renin\u2013angiotensin system","volume":"2015","author":"Santoro","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ejim.2015.12.014_bb0085","first-page":"27","article-title":"Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells","volume":"6","author":"Lezaic","year":"2001","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.ejim.2015.12.014_bb0090","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1525-1594.1985.tb04374.x","article-title":"Erythroid progenitor growth in erythrocytosic posttransplant erythrocytosis","volume":"9","author":"Lamperi","year":"1985","journal-title":"Artif Organs"},{"key":"10.1016\/j.ejim.2015.12.014_bb0095","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/00007890-200010270-00011","article-title":"Expression of angiotensin II type I receptor on erythroid progenitors of patients with post-transplant erythrocytosis","volume":"70","author":"Gupta","year":"2000","journal-title":"Transplantation"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620515004422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620515004422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T03:16:15Z","timestamp":1654053375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620515004422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":19,"alternative-id":["S0953620515004422"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2015.12.014","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renin\u2013angiotensin\u2013aldosterone system inhibitors lower hemoglobin and hematocrit only in renal transplant recipients with initially higher levels","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2015.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}